News Novo aims for GLP-1 sales growth in China Novo expects Victoza and semaglutide to gain momentum.
Views & Analysis Pharma partners with African countries on chronic diseases An innovative programme is being rolled out across Kenya.
News Takeda preps for further acquisition Japanese firm has set money aside for emerging markets M&A.
Views & Analysis Going beyond CSR to reach ‘the two billion’ Impact of putting access to medicine at the core of pharma businesses.
Views & Analysis Disrupting healthcare: 4 lessons from emerging markets Ingenious low-cost solutions to healthcare problems in the developing world can inspire change in global healthcare.
News GSK settles US bribery probe for $20m Actions of Chinese subsidiaries violated US bribery laws, says SEC.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
